Invasive cervical cancer disproportionately affects women without sufficient access to care, with higher rates among minority groups in higher-income countries and women in low-resource regions of the world. Many elements contribute to racial/ethnic disparities in the cervical cancer continuum - from screening and diagnosis to treatment and outcome. Sociodemographic factors, access to healthcare, income and education level, and disease stage at diagnosis are closely linked to such inequities. Despite the identification of such elements, racial/ethnic disparities persist, and are widening in several minority subgroups, particularly in older women, who are ineligible for human papillomavirus (HPV) vaccination and are underscreened. Recent studies suggest that racial/ethnic differences in HPV infection exist and may also have a role in observed differences in cervical cancer. In this review, we provide an overview of the current literature on racial disparities in cervical cancer screening, incidence, treatment and outcome to inform future strategies to reduce persistent inequities.

Keywords:
Cervical cancer screening, Disparity, Race, Ethnicity
1.
Bychkovsky BL, Ferreyra ME, Strasser-Weippl K, Herold CI, de Lima Lopes G Jr, Dizon DS, Schmeler KM, Del Carmen M, Randall TC, Nogueira-Rodrigues A, de Carvalho Calabrich AF, St Louis J, Vail CM, Goss PE: Cervical cancer control in Latin America: a call to action. Cancer 2016;122:502-514.
2.
Torre LA, Siegel RL, Ward EM, Jemal A: Global cancer incidence and mortality rates and trends - an update. Cancer Epidemiol Biomarkers Prev 2016;25:16-27.
3.
Pimple S, Mishra G, Shastri S: Global strategies for cervical cancer prevention. Curr Opin Obstet Gynecol 2016;28:4-10.
4.
Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
5.
Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Steinau M, Markowitz LE: Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis 2012;206:1878-1886.
6.
Ponten J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparen P, Trichopoulos D: Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26.
7.
Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M: Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer 1999;83:59-65.
8.
Quinn M, Babb P, Jones J, Allen E: Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999;318:904-908.
9.
Bruni L B-RL, Albero G, Aldea M, Serrano B, Valencia S, Brotons M, Mena M, Cosano R, Muñoz J, Bosch FX, de Sanjosé S, Castellsagué X; ICO Information Centre on HPV and Cancer (HPV Information Centre): Human papillomavirus and related diseases in the world: summary report. Barcelona, Institut Català d'Oncologia, 2016.
10.
Syrjanen S, Shabalova IP, Petrovichev N, Kozachenko VP, Zakharova T, Pajanidi J, Podistov JI, Chemeris G, Sozaeva LG, Lipova EV, Tsidaeva I, Ivanchenko OG, Pshepurko AA, Zakharenko S, Nerovjna R, Kljukina LB, Erokhina OA, Branovskaja MF, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrjanen KJ: Human papillomavirus testing and conventional pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the former Soviet Union. J Low Genit Tract Dis 2002;6:97-110.
11.
Syrjanen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, Lorincz A, Dores GB, Costa S, Syrjanen S: Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res 2005;25:3469-3480.
12.
Walmer DK, Eder PS, Bell L, Salim H, Kobayashi L, Ndirangu J, Tinfo N, Castle PE: Human papillomavirus prevalence in a population of women living in Port-au-Prince and Leogane, Haiti. PLoS One 2013;8: e76110.
13.
Di JL, Rutherford S, Wu JL, Song B, Ma L, Chen JY, Chu C: Knowledge of cervical cancer screening among health care workers providing services across different socio-economic regions of China. Asian Pac J Cancer Prev 2016;17:2965-2972.
14.
Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA: HPV screening for cervical cancer in rural India. New Engl J Med 2009;360:1385-1394.
15.
Sreedevi A, Javed R, Dinesh A: Epidemiology of cervical cancer with special focus on India. Int J Womens Health 2015;7:405-414.
16.
Gakidou E, Nordhagen S, Obermeyer Z: Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 2008;5:e132.
17.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
18.
Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al: The global burden of cancer 2013. JAMA Oncol 2015;1:505-527.
19.
Khan HM, Gabbidon K, Abdool-Ghany F, Saxena A, Gomez E, Stewart TS: Health disparities between Black Hispanic and Black non-Hispanic cervical cancer cases in the USA. Asian Pac J Cancer Prev 2014;15:9719-9723.
20.
Chatterjee S, Gupta D, Caputo TA, Holcomb K: Disparities in gynecological malignancies. Front Oncol 2016;6:36.
21.
Sheppard CS, El-Zein M, Ramanakumar AV, Ferenczy A, Franco EL: Assessment of mediators of racial disparities in cervical cancer survival in the United States. Int J Cancer 2016;138:2622-2630.
22.
Adams SA, Fleming A, Brandt HM, Hurley D, Bolick-Aldrich S, Bond SM, Hebert JR: Racial disparities in cervical cancer mortality in an African American and European American cohort in South Carolina. J SC Med Assoc 2009;105:237-244.
23.
Tabatabai MA, Kengwoung-Keumo JJ, Eby WM, Bae S, Guemmegne JT, Manne U, Fouad M, Partridge EE, Singh KP: Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model. PLoS One 2014;9:e107242.
24.
Cohen TF, Legg JS: Factors associated with HPV vaccine use among Hispanic college students. J Allied Health 2014;43:241-246.
25.
Eng TY, Chen T, Vincent J, Patel AJ, Clyburn V, Ha CS: Persistent disparities in Hispanics with cervical cancer in a major city. J Racial Ethn Health Disparities 2016, Epub ahead of print.
26.
Yang DX, Soulos PR, Davis B, Gross CP, Yu JB: Impact of widespread cervical cancer screening: number of cancers prevented and changes in race-specific incidence. Am J Clin Oncol 2016, Epub ahead of print.
27.
Ibanez R, Alejo M, Combalia N, Tarroch X, Autonell J, Codina L, Culubret M, Bosch FX, de Sanjose S: Underscreened women remain overrepresented in the pool of cervical cancer cases in Spain: a need to rethink the screening interventions. BioMed Res Int 2015;2015:605375.
28.
Nghiem VT, Davies KR, Chan W, Mulla ZD, Cantor SB: Disparities in cervical cancer survival among Asian-American women. Ann Epidemiol 2016;26:28-35.
29.
Vidal AC, Skaar D, Maguire R, Dodor S, Musselwhite LW, Bartlett JA, Oneko O, Obure J, Mlay P, Murphy SK, Hoyo C: IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 versus non-HPV16/18 genotypes. Infect Agents Cancer 2015;10:10.
30.
Sabatino SA, White MC, Thompson TD, Klabunde CN; Centers for Disease Control and Prevention: Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:464-468.
31.
Weragoda J, Azuero A, Badiga S, Bell WC, Matthews R, Piyathilake C: An examination of racial differences in 5-year survival of cervical cancer among African American and white American women in the southeastern US from 1985 to 2010. Cancer Med 2016;5:2126-2135.
32.
Khan HM, Gabbidon K, Saxena A, Abdool-Ghany F, Dodge JM 3rd, Lenzmeier T: Disparities in cervical cancer characteristics and survival between white Hispanics and white non-Hispanic women. J Womens Health (Larchmt) 2016;25:1052-1058.
33.
Martires KJ, Kurlander DE, Minwell GJ, Dahms EB, Bordeaux JS: Patterns of cancer screening in primary care from 2005 to 2010. Cancer 2014;120:253-261.
34.
Saghari S, Ghamsary M, Marie-Mitchell A, Oda K, Morgan JW: Sociodemographic predictors of delayed- versus early-stage cervical cancer in California. Ann Epidemiol 2015;25:250-255.
35.
Zhan FB, Lin Y: Racial/ethnic, socioeconomic, and geographic disparities of cervical cancer advanced-stage diagnosis in Texas. Womens Health Issues 2014;24:519-527.
36.
Waggaman C, Julian P, Niccolai LM: Interactive effects of individual and neighborhood race and ethnicity on rates of high-grade cervical lesions. Cancer Epidemiol 2014;38:248-252.
37.
Sherman SM, Castanon A, Moss E, Redman CW: Cervical cancer is not just a young woman's disease. BMJ 2015;350:h2729.
38.
Lourenco AV, Fregnani CM, Silva PC, Latorre MR, Fregnani JH: Why are women with cervical cancer not being diagnosed in preinvasive phase? An analysis of risk factors using a hierarchical model. Int J Gynecol Cancer 2012;22:645-653.
39.
UK CR: Cervical cancer incidence statistics. wwwcancerresearchukorg/cancer-info/cancerstats/types/cervix/incidence/#age 2014.
40.
Cancer Research UK: Cervical cancer mortality statistics. 2014. www.cancerresearchuk.org/cancer-info/cancerstats/types/cervix/mortality.
41.
Charlot M, Santana MC, Chen CA, Bak S, Heeren TC, Battaglia TA, Egan AP, Kalish R, Freund KM: Impact of patient and navigator race and language concordance on care after cancer screening abnormalities. Cancer 2015;121:1477-1483.
42.
Brooks SE: Cervical cancer screening and the older woman: obstacles and opportunities. Cancer Pract 1996;4:125-129.
43.
Akers AY, Newmann SJ, Smith JS: Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 2007;31:157-181.
44.
Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W: Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obst Gynecol 2005;105:1323-1328.
45.
Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, Yood MU, Gilbert J, Taplin SH: Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005;97:675-683.
46.
Calle EE, Flanders WD, Thun MJ, Martin LM: Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health 1993;83:53-60.
47.
Castanon A, Landy R, Cuzick J, Sasieni P: Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study. PLoS Med 2014;11:e1001585.
48.
Rositch AF, Nowak RG, Gravitt PE: Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer 2014;120:2032-2038.
49.
Tabnak F, Muller HG, Wang JL, Zhang W, Howell LP: Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women. Cancer Causes Control 2010;21:411-420.
50.
Freund KM, Battaglia TA, Calhoun E, Darnell JS, Dudley DJ, Fiscella K, Hare ML, LaVerda N, Lee JH, Levine P, Murray DM, Patierno SR, Raich PC, Roetzheim RG, Simon M, Snyder FR, Warren-Mears V, Whitley EM, Winters P, Young GS, Paskett ED; Writing Group of the Patient Navigation Research Program: Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. J Natl Cancer Inst 2014;106:dju115.
51.
Glick SB, Clarke AR, Blanchard A, Whitaker AK: Cervical cancer screening, diagnosis and treatment interventions for racial and ethnic minorities: a systematic review. J Gen Intern Med 2012;27:1016-1032.
52.
Coker AL, Eggleston KS, Du XL, Ramondetta L: Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. Int J Gynecol Cancer 2009;19:13-20.
53.
Howell EA, Chen YT, Concato J: Differences in cervical cancer mortality among black and white women. Obstet Gynecol 1999;94:509-515.
54.
Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S: Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol 1998;71:151-158.
55.
Patel DA, Barnholtz-Sloan JS, Patel MK, Malone JM Jr, Chuba PJ, Schwartz K: A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of surveillance, epidemiology, and end results data. Gynecol Oncol 2005;97:550-558.
56.
Benard VB, Howe W, Saraiya M, Helsel W, Lawson HW: Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005. J Low Genit Tract Dis 2008;12:300-306.
57.
Shavers VL, Brown ML: Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94:334-357.
58.
Merrill RM, Merrill AV, Mayer LS: Factors associated with no surgery or radiation therapy for invasive cervical cancer in Black and White women. Ethn Dis 2000;10:248-256.
59.
Rauh-Hain JA, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman A, Boruta DM 2nd, Schorge JO, del Carmen MG: Racial disparities in cervical cancer survival over time. Cancer 2013;119:3644-3652.
60.
Hall WJ, Chapman MV, Lee KM, Merino YM, Thomas TW, Payne BK, Eng E, Day SH, Coyne-Beasley T: Implicit racial/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review. Am J Public Health 2015;105:e60-e76.
61.
Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dube R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ: The effect of race and sex on physicians' recommendations for cardiac catheterization. New Engl J Med 1999;340:618-626.
62.
Farley JH, Hines JF, Taylor RR, Carlson JW, Parker MF, Kost ER, Rogers SJ, Harrison TA, Macri CI, Parham GP: Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer 2001;91:869-873.
63.
Kirsner RS, Ma F, Fleming L, Trapido E, Duncan R, Federman DG, Wilkinson JD: The effect of Medicare health care systems on women with breast and cervical cancer. Obstet Gynecol 2005;105:1381-1388.
64.
Robbins AS, Han X, Ward EM, Simard EP, Zheng Z, Jemal A: Association between the Affordable Care Act Dependent Coverage Expansion and cervical cancer stage and treatment in young women. JAMA 2015;314:2189-2191.
65.
Shi L, Chen CC, Nie X, Zhu J, Hu R: Racial and socioeconomic disparities in access to primary care among people with chronic conditions. J Am Board Fam Med 2014;27:189-198.
66.
Hall HI, Jamison PM, Coughlin SS, Uhler RJ: Breast and cervical cancer screening among Mississippi Delta women. J Health Care Poor Underserved 2004;15:375-389.
67.
Bradley CJ, Given CW, Roberts C: Health care disparities and cervical cancer. Am J Public Health 2004;94:2098-2103.
68.
Centers for Disease Control and Prevention: Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61:41-45.
69.
Kirby JB, Kaneda T: Unhealthy and uninsured: exploring racial differences in health and health insurance coverage using a life table approach. Demography 2010;47:1035-1051.
70.
Sung JF, Alema-Mensah E, Blumenthal DS: Inner-city African American women who failed to receive cancer screening following a culturally-appropriate intervention: the role of health insurance. Cancer Detect Prev 2002;26:28-32.
71.
O'Malley AS, Mandelblatt J, Gold K, Cagney KA, Kerner J: Continuity of care and the use of breast and cervical cancer screening services in a multiethnic community. Arch Int Med 1997;157:1462-1470.
72.
Hiatt RA, Pasick RJ, Stewart S, Bloom J, Davis P, Gardiner P, Johnston M, Luce J, Schorr K, Brunner W, Stroud F: Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med 2001;33:190-203.
73.
Byrd TL, Peterson SK, Chavez R, Heckert A: Cervical cancer screening beliefs among young Hispanic women. Prev Med 2004;38:192-197.
74.
Sabik LM, Tarazi WW, Bradley CJ: State Medicaid expansion decisions and disparities in women's cancer screening. Am J Prev Med 2015;48:98-103.
75.
Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M: Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011;378:1461-1484.
76.
Girianelli VR, Gamarra CJ, Azevedo e Silva G: Disparities in cervical and breast cancer mortality in Brazil. Rev Saude Publica 2014;48:459-467.
77.
Nuno T, Gerald JK, Harris R, Martinez ME, Estrada A, Garcia F: Comparison of breast and cervical cancer screening utilization among rural and urban Hispanic and American Indian women in the Southwestern United States. Cancer Causes Control 2012;23:1333-1341.
78.
Baker P, Hoel D, Mohr L, Lipsitz S, Lackland D: Racial, age, and rural/urban disparity in cervical cancer incidence. Ann Epidemiol 2000;10:466-467.
79.
Mickey RM, Durski J, Worden JK, Danigelis NL: Breast cancer screening and associated factors for low-income African-American women. Prev Med 1995;24:467-476.
80.
American Joint Committee on Cancer: AJCC Cancer Staging Manual, ed 7. Chicago, AJCC, 2009.
81.
Coughlin SS, King J, Richards TB, Ekwueme DU: Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev 2006;15:2154-2159.
82.
Garbers S, Jessop DJ, Foti H, Uribelarrea M, Chiasson MA: Barriers to breast cancer screening for low-income Mexican and Dominican women in New York City. J Urban Health 2003;80:81-91.
83.
Pruitt SL, Shim MJ, Mullen PD, Vernon SW, Amick BC 3rd: Association of area socioeconomic status and breast, cervical, and colorectal cancer screening: a systematic review. Cancer Epidemiol Biomarkers Prev 2009;18:2579-2599.
84.
Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L: Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis. Cancer 2006;106:664-669.
85.
Nielsen-Bohlman L, Panzer AM, Kindig DA (eds): Health Literacy: A Prescription to End Confusion. Washington, Institute of Medicine, 2004.
86.
Lindau ST, Tomori C, Lyons T, Langseth L, Bennett CL, Garcia P: The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol 2002;186:938-943.
87.
Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA 1999;281:552-557.
88.
Banister CE, Messersmith AR, Cai B, Spiryda LB, Glover SH, Pirisi L, Creek KE: Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J Infect Dis 2015;211:100-108.
89.
Garner EI: Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 2003;12:242s-247s.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.